UNSPSC 51313116: Chlorcyclizine pamoate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C23H16O6.C18H21ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 73R47NSS6P, chemically known as 2-naphthalenecarboxylic acid, 4,4'-methylenebis 3-hydroxy-, compd. with 1-((4-chlorophenyl)phenylmethyl)-4-methylpiperazine, but more generally known as chlorcyclizine pamoate, which bears US NIH Compound Identifier 24296.

European Medicines Agency schedules chlorcyclizine pamoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06178MIG. Most nations, for tariff purposes, schedule chlorcyclizine pamoate under HS 29335995. SMILES: CN1CCN(CC1)C(C2CCCCC2)C3CCC(CC3)CL.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O.

UNSPSC 51313116 Chlorcyclizine pamoate is a Commodity code that nominally covers a specific antihistamine pharmaceutical product, but the recent state and local procurement activity recorded under this code does not reflect pharmaceutical procurement aligned with the code's name. The single recent opportunity tagged to this code—Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—involves procurement of emergency overdose-reversal medication and drug disposal equipment rather than chlorcyclizine pamoate. This mismatch suggests either a data classification error in the procurement system or a misapplication of the UNSPSC code to the actual goods being solicited. The code shows minimal recent activity and appears unsuitable for business development targeting legitimate chlorcyclizine pamoate procurement.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. Vendors must include all shipping and delivery costs in their bids, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract term runs two years with an option for one-year renewal. The procurement contains no explicit set-aside designations and may be FEMA-funded, introducing federal compliance requirements. Given the disconnect between the code's pharmaceutical scope and the actual goods solicited, practitioners should verify UNSPSC coding accuracy before pursuing opportunities listed under this commodity.